Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

CEBP Focus: Biomarkers and Biospecimens

Molecular Pathology in Epidemiologic Studies: A Primer on Key Considerations

Mark E. Sherman, Will Howatt, Fiona M. Blows, Paul Pharoah, Stephen M. Hewitt and Montserrat Garcia-Closas
Mark E. Sherman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Will Howatt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fiona M. Blows
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Pharoah
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen M. Hewitt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Montserrat Garcia-Closas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-10-0056 Published April 2010
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    The patients for whom research tissues are available in epidemiologic studies reflects multiple factors related to diagnosis and treatment. These practices may vary between populations, geographic regions and calendar periods, and by patient and tumor features. Practices of tissue sampling and preparation for diagnosis may vary with the type of procedure used to collect the sample, the clinical context, and institutional protocols. All of the above may affect assay performance. In large studies, efforts to standardize, optimize, and automate performance and scoring of assays are important to control costs, speed completion of studies, and minimize variability. Computer infrastructure is important throughout the “cycle,” to provide tracking, data management, and facilitate downstream statistical analysis.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    TMAs facilitate rapid, cost-effective high-throughput analysis of large tumor sets. Target areas within individual donor blocks are identified by examining corresponding H&E-stained tissue sections. Cylindrical cores are removed with semiautomated devices from each donor block and arrayed in a precise matrix in the recipient block to create the TMA. Assays done on single sections cut from TMA blocks enable the batched analysis of multiple tumors. Reprinted with permission: Kallioniemi O-P et al., TMA technology for high-throughput molecular profiling of cancer, Human Molecular Genetics, 2001, volume 10, issue 7: 657-62 (27).

Tables

  • Figures
  • Table 1.

    TMAs: selected design considerations

    Design considerationProsCons
    Increased cores/sampleReduces missing dataIncreases effort
    Captures heterogeneity
    Larger core diameterBetter target representationFewer cores/TMA
    Replicate cores separated in different TMAsProtects material if one TMA block lostNeed to ensure consistency
    More cores/TMAReduces assay costsMapping more difficult
    Grouping cores within TMA blocks by subject or tumor characteristicsConserves material for relevant assaysNeed to ensure consistency
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 19 (4)
April 2010
Volume 19, Issue 4
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Molecular Pathology in Epidemiologic Studies: A Primer on Key Considerations
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Molecular Pathology in Epidemiologic Studies: A Primer on Key Considerations
Mark E. Sherman, Will Howatt, Fiona M. Blows, Paul Pharoah, Stephen M. Hewitt and Montserrat Garcia-Closas
Cancer Epidemiol Biomarkers Prev April 1 2010 (19) (4) 966-972; DOI: 10.1158/1055-9965.EPI-10-0056

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Molecular Pathology in Epidemiologic Studies: A Primer on Key Considerations
Mark E. Sherman, Will Howatt, Fiona M. Blows, Paul Pharoah, Stephen M. Hewitt and Montserrat Garcia-Closas
Cancer Epidemiol Biomarkers Prev April 1 2010 (19) (4) 966-972; DOI: 10.1158/1055-9965.EPI-10-0056
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Background
    • Availability of Tissue: Ensuring Representativeness of Samples
    • Effect of Study Design
    • Tissue Preservation and Fixation
    • Assembling Tissues for Research
    • Tissue Microarrays for High-Throughput Analysis
    • Designing TMAs
    • Tissue Cores for Molecular Studies
    • Test Arrays and Cores
    • Sectioning and Staining TMAs
    • Scoring
    • Future Directions
    • Disclosure of Potential Conflicts of Interest
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

CEBP Focus: Biomarkers and Biospecimens

  • SPREC: Sample PREanalytical Code
  • Epitope Variability in Immunohistochemistry
  • Automated Image Analysis of Breast Cancer TMAs
Show more CEBP Focus: Biomarkers and Biospecimens

Minireview

  • Black and White Differences in Colorectal Cancer
  • Geospatial Research Methods in Canadian Population Oncology
  • Repeat Screening with Fecal Occult Blood Tests
Show more Minireview
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement